vs
Side-by-side financial comparison of Dexcom (DXCM) and VALMONT INDUSTRIES INC (VMI). Click either name above to swap in a different company.
Dexcom is the larger business by last-quarter revenue ($1.3B vs $1.0B, roughly 1.2× VALMONT INDUSTRIES INC). Dexcom runs the higher net margin — 21.2% vs 10.5%, a 10.7% gap on every dollar of revenue. On growth, Dexcom posted the faster year-over-year revenue change (21.6% vs 6.2%). Over the past eight quarters, Dexcom's revenue compounded faster (12.0% CAGR vs -0.5%).
Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S.A. and manufacturing facilities in Mesa, Arizona, U.S.A.; Batu Kawan, Malaysia and Athenry, County Galway, Ireland.
Valmont Industries, Inc. is a large, publicly held American manufacturer of Valley center pivot and linear irrigation equipment, windmill support structures, lighting and traffic poles and steel utility poles.
DXCM vs VMI — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $1.3B | $1.0B |
| Net Profit | $267.3M | $108.0M |
| Gross Margin | 62.9% | 30.8% |
| Operating Margin | 25.6% | 15.1% |
| Net Margin | 21.2% | 10.5% |
| Revenue YoY | 21.6% | 6.2% |
| Net Profit YoY | 153.6% | 23.8% |
| EPS (diluted) | $0.67 | $5.51 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $1.3B | $1.0B | ||
| Q4 25 | $1.3B | $1.0B | ||
| Q3 25 | $1.2B | $1.0B | ||
| Q2 25 | $1.2B | $1.1B | ||
| Q1 25 | $1.0B | $969.3M | ||
| Q4 24 | $1.1B | $1.0B | ||
| Q3 24 | $994.2M | $1.0B | ||
| Q2 24 | $1.0B | $1.0B |
| Q1 26 | $267.3M | $108.0M | ||
| Q4 25 | $267.3M | $168.0M | ||
| Q3 25 | $283.8M | $99.0M | ||
| Q2 25 | $179.8M | $-4.0M | ||
| Q1 25 | $105.4M | $87.3M | ||
| Q4 24 | $151.7M | $77.7M | ||
| Q3 24 | $134.6M | $83.1M | ||
| Q2 24 | $143.5M | $99.7M |
| Q1 26 | 62.9% | 30.8% | ||
| Q4 25 | 62.9% | 29.8% | ||
| Q3 25 | 60.5% | 30.4% | ||
| Q2 25 | 59.5% | 30.6% | ||
| Q1 25 | 56.9% | 30.0% | ||
| Q4 24 | 58.9% | 30.2% | ||
| Q3 24 | 59.7% | 29.6% | ||
| Q2 24 | 62.4% | 30.8% |
| Q1 26 | 25.6% | 15.1% | ||
| Q4 25 | 25.6% | 11.2% | ||
| Q3 25 | 20.1% | 13.5% | ||
| Q2 25 | 18.4% | 2.8% | ||
| Q1 25 | 12.9% | 13.2% | ||
| Q4 24 | 17.0% | 11.6% | ||
| Q3 24 | 15.3% | 12.3% | ||
| Q2 24 | 15.7% | 14.2% |
| Q1 26 | 21.2% | 10.5% | ||
| Q4 25 | 21.2% | 16.2% | ||
| Q3 25 | 23.5% | 9.5% | ||
| Q2 25 | 15.5% | -0.4% | ||
| Q1 25 | 10.2% | 9.0% | ||
| Q4 24 | 13.6% | 7.5% | ||
| Q3 24 | 13.5% | 8.1% | ||
| Q2 24 | 14.3% | 9.6% |
| Q1 26 | $0.67 | $5.51 | ||
| Q4 25 | $0.67 | $9.02 | ||
| Q3 25 | $0.70 | $4.98 | ||
| Q2 25 | $0.45 | $-1.53 | ||
| Q1 25 | $0.27 | $4.32 | ||
| Q4 24 | $0.37 | $3.85 | ||
| Q3 24 | $0.34 | $4.11 | ||
| Q2 24 | $0.35 | $4.91 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $917.7M | $160.2M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $2.7B | $1.7B |
| Total Assets | $6.3B | $3.4B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $917.7M | $160.2M | ||
| Q4 25 | $917.7M | $187.1M | ||
| Q3 25 | $1.8B | $226.1M | ||
| Q2 25 | $1.2B | $208.5M | ||
| Q1 25 | $904.9M | $184.4M | ||
| Q4 24 | $606.1M | $164.3M | ||
| Q3 24 | $621.2M | $200.5M | ||
| Q2 24 | $939.2M | $163.1M |
| Q1 26 | — | — | ||
| Q4 25 | — | $795.7M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $730.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | $2.7B | $1.7B | ||
| Q4 25 | $2.7B | $1.6B | ||
| Q3 25 | $2.7B | $1.6B | ||
| Q2 25 | $2.6B | $1.5B | ||
| Q1 25 | $2.3B | $1.6B | ||
| Q4 24 | $2.1B | $1.5B | ||
| Q3 24 | $2.0B | $1.5B | ||
| Q2 24 | $2.4B | $1.5B |
| Q1 26 | $6.3B | $3.4B | ||
| Q4 25 | $6.3B | $3.4B | ||
| Q3 25 | $7.5B | $3.4B | ||
| Q2 25 | $7.3B | $3.3B | ||
| Q1 25 | $6.8B | $3.4B | ||
| Q4 24 | $6.5B | $3.3B | ||
| Q3 24 | $6.4B | $3.5B | ||
| Q2 24 | $6.8B | $3.5B |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.49× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.47× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DXCM
Segment breakdown not available.
VMI
| Infrastructure | $803.2M | 78% |
| Agriculture | $226.0M | 22% |
